IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Brésil |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Afrique du Sud |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Chine |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Équateur |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Égypte |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Indonésie |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Bangladesh |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Fédération de Russie |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
États-Unis d'Amérique |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Canada |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Union européenne |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Chili |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Australie |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Suisse |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Japon |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Corée, République de |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Bolivie, État plurinational de |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Norvège |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Afrique du Sud |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Saint-Siège |
08/11/2016-09/11/2016 |
30/01/2017 |
|